Search Results

There are 12623 results for: content related to: Lamivudine prophylaxis for prevention of chemotherapy-induced hepatitis B virus reactivation in hepatitis B virus carriers with malignancies

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. You have free access to this content
    A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial

    Hepatology

    Volume 47, Issue 3, March 2008, Pages: 844–853, Chiun Hsu, Chao A. Hsiung, Ih-Jen Su, Wei-Shou Hwang, Ming-Chung Wang, Sheng-Fung Lin, Tseng-Hsi Lin, Hui-Hua Hsiao, Ji-Hsiung Young, Ming-Chih Chang, Yu-Min Liao, Chi-Cheng Li, Hung-Bo Wu, Hwei-Fang Tien, Tsu-Yi Chao, Tsang-Wu Liu, Ann-Lii Cheng and Pei-Jer Chen

    Version of Record online : 27 DEC 2007, DOI: 10.1002/hep.22106

  3. You have free access to this content
    Beneficial Effects of Short-Term Lamivudine Treatment for de novo Hepatitis B Virus Reactivation After Liver Transplantation

    American Journal of Transplantation

    Volume 6, Issue 11, November 2006, Pages: 2680–2685, M. Umeda, H. Marusawa, M. Ueda, Y. Takada, H. Egawa, S. Uemoto and T. Chiba

    Version of Record online : 16 OCT 2006, DOI: 10.1111/j.1600-6143.2006.01542.x

  4. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  5. Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and reactivation-related mortality in chemotherapy patients: a meta-analysis

    Liver International

    Volume 28, Issue 1, January 2008, Pages: 28–38, Lenna A. Martyak, Ehsan Taqavi and Sammy Saab

    Version of Record online : 1 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01618.x

  6. You have free access to this content
    Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

    Alimentary Pharmacology & Therapeutics

    Volume 24, Issue 7, October 2006, Pages: 1003–1016, H. E. KOHRT, D. L. OUYANG and E. B. KEEFFE

    Version of Record online : 12 SEP 2006, DOI: 10.1111/j.1365-2036.2006.03081.x

  7. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy

    Journal of Medical Virology

    Volume 59, Issue 3, November 1999, Pages: 263–269, Winnie Yeo, Joyce L. Steinberg, John S. Tam, Paul K.S. Chan, Nancy W.Y. Leung, Kwok C. Lam, Tony S.K. Mok and Philip J. Johnson

    Version of Record online : 27 SEP 1999, DOI: 10.1002/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.0.CO;2-X

  8. Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation

    Hematological Oncology

    Volume 34, Issue 3, September 2016, Pages: 140–146, Alok Gupta, Sachin Punatar, Jayant Gawande, Bhausaheb Bagal, Libin Mathew, Vivek Bhat, Sadhana Kannan and Navin Khattry

    Version of Record online : 18 FEB 2015, DOI: 10.1002/hon.2195

  9. Hepatitis B reactivation in allogeneic hemopoietic stem cell transplantation setting: A pediatric experience

    Pediatric Transplantation

    Volume 13, Issue 7, November 2009, Pages: 923–926, M. Faraci, B. Cappelli, E. Lanino, G. Morreale, F. Fioredda, C. L. Giudice and R. Giacchino

    Version of Record online : 19 NOV 2008, DOI: 10.1111/j.1399-3046.2008.01080.x

  10. Prophylactic effect of lamivudine on chemotherapy-induced hepatitis B virus reactivation in patients with solid tumour: A meta-analysis

    European Journal of Cancer Care

    Z. Xu, W. Dai, Y.-T. Wu, B. Arshad, X. Li, H. Wu, H.-R. Chen, K.-N. Wu and L.-Q. Kong

    Version of Record online : 19 DEC 2017, DOI: 10.1111/ecc.12799

  11. Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy and the role of preemptive lamivudine administration

    Liver International

    Volume 24, Issue 6, December 2004, Pages: 540–546, M. S. Dai, P. F. Wu, R. Y. Shyu, J. J. Lu and T. Y. Chao

    Version of Record online : 26 NOV 2004, DOI: 10.1111/j.1478-3231.2004.0964.x

  12. You have free access to this content
    Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: Diagnosis and management

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 5, May 2010, Pages: 864–871, John S Lubel and Peter W Angus

    Version of Record online : 28 APR 2010, DOI: 10.1111/j.1440-1746.2010.06243.x

  13. Outcomes and risk factors for hepatitis B virus (HBV) reactivation after kidney transplantation in occult HBV carriers

    Transplant Infectious Disease

    Volume 15, Issue 3, June 2013, Pages: 300–305, G.-D. Chen, J.-L. Gu, J. Qiu and L.-Z. Chen

    Version of Record online : 8 MAR 2013, DOI: 10.1111/tid.12065

  14. Hepatitis B virus reactivation associated with anti-neoplastic therapy

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 1, January 2013, Pages: 31–37, Winnie Yeo and Henry LY Chan

    Version of Record online : 19 DEC 2012, DOI: 10.1111/j.1440-1746.2012.07280.x

  15. You have free access to this content
    Abstracts 890 to 1096

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 632A–724A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22020

  16. You have free access to this content
    Hepatitis B prophylaxis in patients undergoing chemotherapy for lymphoma: A decision analysis model

    Hepatology

    Volume 46, Issue 4, October 2007, Pages: 1049–1056, Sammy Saab, Mamie H. Dong, Tom A. Joseph and Myron J. Tong

    Version of Record online : 6 AUG 2007, DOI: 10.1002/hep.21783

  17. Reactivation of overt and occult hepatitis B infection in various immunosuppressive settings

    Journal of Medical Virology

    Volume 83, Issue 11, November 2011, Pages: 1909–1916, Nicola Coppola, Gilda Tonziello, Mariantonietta Pisaturo, Vincenzo Messina, Salvatore Guastafierro, Marco Fiore, Valentina Iodice, Caterina Sagnelli, Maria Stanzione, Nicolina Capoluongo, Giuseppe Pasquale and Evangelista Sagnelli

    Version of Record online : 23 AUG 2011, DOI: 10.1002/jmv.22199

  18. You have free access to this content
    Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma

    Cancer

    Volume 106, Issue 6, 15 March 2006, Pages: 1320–1325, Yu-Hong Li, Yi-Fu He, Wen-Qi Jiang, Fen-Hua Wang, Xu-Bin Lin, Li Zhang, Zhong-Jun Xia, Xiao-Fei Sun, Hui-Qiang Huang, Tong-Yu Lin, You-Jian He and Zhong-Zhen Guan

    Version of Record online : 8 FEB 2006, DOI: 10.1002/cncr.21701

  19. You have free access to this content
    A randomized controlled study of preemptive lamivudine in patients receiving transarterial chemo-lipiodolization

    Hepatology

    Volume 43, Issue 2, February 2006, Pages: 233–240, Jeong Won Jang, Jong Young Choi, Si Hyun Bae, Seung Kew Yoon, U Im Chang, Chang Wook Kim, Se Hyun Cho, Jun Yeol Han and Young Sok Lee

    Version of Record online : 26 JAN 2006, DOI: 10.1002/hep.21024

  20. Entecavir versus lamivudine for hepatitis B prophylaxis in patients with haematological disease

    Liver International

    Volume 33, Issue 8, September 2013, Pages: 1203–1210, Fei W. Chen, Luke Coyle, Brett E. Jones and Venessa Pattullo

    Version of Record online : 24 MAR 2013, DOI: 10.1111/liv.12154